Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
PONIARD PHARM Add to My Watchlist (NSDQ: PARD) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Poniard 1.66 +0.02 (+1.22%) 1,335,891
7000 Shoreline Court
Suite 270
South San Francisco, CA 94080 US
(650) 583-3774
(650) 583-3789 fax
www.poniard.com
CEO Ronald A. Martell
Auditor KPMG LLP
Exchange Traded NQ
ISIN Number US7324493011
CIK Number 755806
NAICS Code 325412
Business Summary
A biopharmaceutical company focused on the development and commercialization of cancer therapy products.
Number of Employees 59
Share Fundamentals
Market Cap 58.04M
Shares Outstanding 34.96M
Float 34.45M
Short Interest 8.53M
Financial Strength
Revenue (TTM) N/A
Earnings (TTM) -$46,489,000
Quick Ratio 2.3:1
Current Ratio 2.4:1
Total Debt/Equity 1.01:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs